Keywords
MedicineAdverse effectDrugIntensive care medicineIrritationDosage formPharmacologyImmunology
Affiliated Institutions
Related Publications
SARS: Systematic Review of Treatment Effects
Despite an extensive literature reporting on SARS treatments, it was not possible to determine whether treatments benefited patients during the SARS outbreak. Some may have been...
Theophylline in the management of asthma: time for reappraisal?
Theophylline has been used for several decades in the treatment of asthma and remains the most widely prescribed anti-asthma drug worldwide, although the development of newer an...
Failing the Public Health — Rofecoxib, Merck, and the FDA
On May 21, 1999, Merck was granted approval by the Food and Drug Administration (FDA) to market rofecoxib (Vioxx). On September 30, 2004, after more than 80 million patients had...
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint i...
Publication Info
- Year
- 1996
- Type
- review
- Volume
- 14
- Issue
- 1
- Pages
- 39-67
- Citations
- 27
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
27
OpenAlex
Cite This
Ijeoma F. Uchegbu,
Alexander T. Florence
(1996).
Adverse Drug Events Related to Dosage Forms and Delivery Systems.
Drug Safety
, 14
(1)
, 39-67.
https://doi.org/10.2165/00002018-199614010-00005
Identifiers
- DOI
- 10.2165/00002018-199614010-00005